期刊文献+

异烟肼乙酰化代谢昼夜节律性的研究 被引量:1

Study on circadian rhythm of isoniaxid acety lated metabolism
下载PDF
导出
摘要 目的与方法 :本文对 6名健康自愿者和 6名结核病人进行了异烟肼乙酰化代谢比率(MR)进行了研究。结果 :表明 MR具有极明显的昼夜节律性 (P<0 .0 1)。表现为下午 15∶ 0 0服药 MR最大 ,早晨 6∶ 0 0和晚上 2 2∶ 0 0服药 MR最小 ,两者比较具有显著性差异 (P<0 .0 1)。结论 :由此推测人体内 N-乙酰转移酶的活性具有明显的昼夜节律性 。 Objective and method [WT5BZ]: This article is about the study on circadian rhythm of isoniazid acetylated metabolism for six healthful volunteers and six phthisics.[WT5HZ]Result:[WT5BZ]The result indicates that the rate of isoniazid acetylated metabolism(MR)has a very manifest circadian rhythm.(P<0.01).It shows:Administration at p.m 15∶00,MR is the biggest;MR is the smallest when administration is at a .m 6∶00 or p.m 22∶00.There is a significant difference between them(P<0.01).Conclusion:According to the results,we guess that the activity of N acetyltransferase in human body has a manifest circadian rhythm. [WT5HZ]
出处 《河北医学》 CAS 2000年第6期513-516,共4页 Hebei Medicine
关键词 异烟肼乙酰化代谢比率 昼夜节律 异烟肼 肺结核 WT5BZ]Isoniazid circadin rhythm N acetyltranferase
  • 相关文献

参考文献4

  • 1戴德银.异烟肼乙酰基转移酶的活性测定[J].中国医药学杂志,1986,6(2):22-22.
  • 2Davis. Drug Reaction and The Liver [M]. London: Pitman,1981.197-201.
  • 3陈良细等.昼夜节律与科学用药[J].人民军医,1987,2:43-43.
  • 4Eidus L,et al. Antimicrode Agents Chemotherapy [J].1973,3(1) :130.

同被引文献17

  • 1张训,侯凡凡.血液透析与肾移植病人的结核感染[J].中华肾脏病杂志,1995,11(1):44-46. 被引量:25
  • 2蒋建平,侯凡凡.慢性肾衰竭并发结核的防治[J].中国血液净化,2006,5(11):795-796. 被引量:22
  • 3王美云.维持性血液透析患者并发结核感染的诊治[J].江苏大学学报(医学版),2007,17(6):503-504. 被引量:5
  • 4Ares G, Yildiz T, Danis R, et al. Incidence of tuberculosis disease and latent tuberculosis infection in patients with end stage renal disease in an endemic region [ J ]. Ren Fail,2010,32 ( 1 ) : 91-95.
  • 5Kazancioglu R, Ozturk S, Gursu M, et al. Tuberculosis in patients on hemodialysis in an endemic region [ J ]. Hemodial Int,2010,14 (4) :505-509.
  • 6Rao TM, Ram R, Swarnalatha G, et al. Tuberculosis in haemodialysis patients : a single centre experience [ J ]. Indian J Nephro1,2013,23 ( 5 ) : 340-345.
  • 7Preziosi P. Isoniazid : metabolic aspects and toxicological correlates [ J ]. Curr Drug Metab,2007,8 ( 8 ) : 839-851.
  • 8Tostmann A, Mtabho CM, Semvua HH. Pharmacokinetics of first- line tuberculosis drugs in Tanzanian patients [ J ]. Antimicrob Agents Chemother,2013,57 (7) :3208-3213.
  • 9Altiparmak MR, Pamuk ON, Pamuk GE, et al. Is isoniazid ototoxic in patients undergoing hemodialysis [ J ]. Nephron, 2002,92 ( 2 ) : 478-480.
  • 10Abdelrabman M, Sinha AK, Karkar A. Tuberculosis in end-stage renal disease patients on hemodialysis [ J ]. Hemodi-alysis International,2006, 10(4) :360-364.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部